首页> 外文OA文献 >Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

【2h】

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

机译：曲妥珠单抗联合吉西他滨和长春瑞滨作为二线治疗HER-2 / neu过表达转移性乳腺癌的方法。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Morabito A; Longo R; Gattuso D; Carillio G; Massaccesi C; Mariani L; Bonginelli P; Amici S; De Sio L; Fanelli M; Torino F; Bonsignori M; Gasparini G.;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 曲妥珠单抗联合多西紫杉醇治疗Her-2/neu高表达转移性乳腺癌的疗效和不良反应 [J] . 周宁宁, 林旭滨, 刘冬耕, 癌症（英文版） . 2008,第009期
2. Efficacy and tolerability of taxanes or vinorelbine chemotherapy with trastuzumab as a first combination in Her-2 overexpressing patients with metastatic breast cancer [J] . I.Glogowska, Sienkiewicz-Kozlowska, E.Szombara, European Journal of Cancer Supplements . 2006,第2期

机译：紫杉烷类药物或长春瑞滨化疗联合曲妥珠单抗作为Her-2过表达转移性乳腺癌患者的第一个组合的疗效和耐受性
3. Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer. [J] . Jerusalem G, Fasolo A, Dieras V, Breast cancer research and treatment. . 2011,第2期

机译：口服mTOR抑制剂依维莫司联合曲妥珠单抗和长春瑞滨在预治疗的HER2过表达转移性乳腺癌患者中进行的I期试验。
4. Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer. [J] . Jerusalem G, Fasolo A, Dieras V, Breast cancer research and treatment. . 2011,第2期

机译：口服mTOR抑制剂依维莫司联合曲妥珠单抗和长春瑞滨在预治疗的HER2过表达转移性乳腺癌患者中进行的I期试验。
5. Engineered Synthetic Peptide Epitopes from the Extracellular Domain of HER-2/neu are Recognized by Trastuzumab [C] . Joan T. Steele, Stephanie D. Allen, Sharad Rawale American Peptide Symposium . 2006

机译：来自Her-2 / Neu细胞外结构域的工程合成肽表位被曲妥珠单抗识别
6. Impact of HER-2/neu detection by fluorescence in situ hybridization (FISH) on trastuzumab therapy in the treatment of metastatic breast cancer. [D] . Subongkot, Suphat. 2003

机译：荧光原位杂交（FISH）检测HER-2 / neu对曲妥珠单抗治疗转移性乳腺癌的影响。
7. Phase II study of lapatinib in combination with vinorelbine as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer [O] . Helen Kent Chew, Lee Schwartzberg, Suprith Badarinath, -1

机译：拉帕替尼联合长春瑞滨作为一线或二线治疗HER2过表达转移性乳腺癌女性的II期研究
8. Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction [O] . Corinna Warburton, Wieslawa H. Dragowska, Karen Gelmon, 2004

机译：用曲妥珠单抗（Herceptin）和Gefitinib（ZD1839）治疗Her-2 / Neu过表达乳腺癌异种癌模型：药物组合对肿瘤生长，Her-2 / Neu和表皮生长因子受体表达，以及可行的缺氧细胞级分
9. Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide- Based Vaccine Administered to Stage IIIB and IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab Monotherapy; Annual rept. 27 Apr 2007-26 Apr 2008 [R] . Disis, M. L. 2008

机译：对接受曲妥珠单抗单一疗法的IIIB和IV期HER2阳性乳腺癌患者施用HER-2 / neu（HER2）细胞内结构域（ICD）基于肽的疫苗的II期研究;年度报告。 2007年4月27日至2008年4月26日

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅